© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 2, 106-111,
January 19, 2000
© 2000 Oxford University Press
Doses of Nicotine and Lung Carcinogens Delivered to Cigarette Smokers
Affiliations of authors: M. V. Djordjevic, Division of Cancer Etiology and Prevention, American Health Foundation, Valhalla, NY; S. D. Stellman (Division of Epidemiology), E. Zang (Biostatistics and Computing Facility), American Health Foundation, New York, NY.
Correspondence to: Mirjana V. Djordjevic, Ph.D., Division of Cancer Etiology and Prevention, American Health Foundation, 1 Dana Rd., Valhalla, NY 10595 (e-mail: Mirjana{at}ix.netcom.com).
BACKGROUND: Cigarette smoke yields of tar and nicotine obtained under the Federal Trade
Commission (FTC)-specified machine-smoking protocol (35-mL puff volume drawn for 2 seconds
once per minute) may not accurately reflect the delivery of toxins and carcinogens to the smoker.
We conducted this study to obtain more realistic estimates of exposure to components of cigarette
smoke that affect lung cancer risk. METHODS: We used a pressure transducer system to evaluate
puffing characteristics for 133 smokers of cigarettes rated by the FTC at 1.2 mg of nicotine or less
(56 smokers of low-yield cigarettes [
0.8 mg of nicotine per cigarette] and 77
smokers of medium-yield cigarettes [0.9-1.2 mg of nicotine per cigarette]). We
programmed measurements from a randomly chosen subset of 72 of these smokers into a
piston-type machine to generate smoke from each smoker's usual brand of cigarettes for
assays of nicotine, carbon monoxide, tar, and the lung cancer-causing agents
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. The
FTC protocol was also used to assess levels of targeted components in the 11 brands most
frequently smoked by study subjects. RESULTS: Compared with the FTC protocol values,
smokers of low- and medium-yield brands took in statistically significantly larger puffs (48.6 and
44.1 mL, respectively) at statistically significantly shorter intervals (21.3 and 18.5 seconds,
respectively), and they drew larger total smoke volumes than specified in the FTC parameters.
They received, respectively, 2.5 and 2.2 times more nicotine and 2.6 and 1.9 times more tar than
FTC-derived amounts, as well as about twofold higher levels of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Smokers of medium-yield
cigarettes compared with smokers of low-yield cigarettes received higher doses of all
components. CONCLUSIONS: The FTC protocol underestimates nicotine and carcinogen doses
to smokers and overestimates the proportional benefit of low-yield cigarettes. Thus, FTC-based
nicotine medication doses prescribed/recommended for smoking cessation may need to be
reassessed.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. J. Alberg, J. G. Ford, and J. M. Samet Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 29S - 55S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Melikian, M. V. Djordjevic, S. Chen, J. Richie Jr., and S. D. Stellman Effect of Delivered Dosage of Cigarette Smoke Toxins on the Levels of Urinary Biomarkers of Exposure Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1408 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W E Stephens Dependence of tar, nicotine and carbon monoxide yields on physical parameters: implications for exposure, emissions control and monitoring Tob. Control, June 1, 2007; 16(3): 170 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Pankow, K. H. Watanabe, P. L. Toccalino, W. Luo, and D. F. Austin Calculated Cancer Risks for Conventional and "Potentially Reduced Exposure Product" Cigarettes Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 584 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Strasser, R. J. O'Connor, M. E. Mooney, and E. P. Wileyto Digital Image Analysis of Cigarette Filter Stains as an Indicator of Compensatory Smoking Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2565 - 2569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Laugesen and J. Fowles Marlboro UltraSmooth: a potentially reduced exposure cigarette? Tob. Control, December 1, 2006; 15(6): 430 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Tindle, N. A. Rigotti, R. B. Davis, E. M. Barbeau, I. Kawachi, and S. Shiffman Cessation Among Smokers of "Light" Cigarettes: Results From the 2000 National Health Interview Survey Am J Public Health, August 1, 2006; 96(8): 1498 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hammond, G. T. Fong, K. M. Cummings, and A. Hyland Smoking Topography, Brand Switching, and Nicotine Delivery: Results from an In vivo Study Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1370 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Gray, J E Henningfield, N L Benowitz, G N Connolly, C Dresler, K Fagerstrom, M J Jarvis, and P Boyle Toward a comprehensive long term nicotine policy Tob. Control, June 1, 2005; 14(3): 161 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kelbsch, C. Meyer, H.-J. Rumpf, U. John, and U. Hapke Stages of change and other factors in 'light' cigarette smokers Eur J Public Health, April 1, 2005; 15(2): 146 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Brooks, J. H.M. Austin, R. T. Heelan, M. S. Ginsberg, V. Shin, S. H. Olson, J. E. Muscat, and S. D. Stellman Influence of Type of Cigarette on Peripheral versus Central Lung Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 576 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. E. Murphy, S. G. Carmella, S. Li, J. Jensen, C. Le, A. M. Joseph, and D. K. Hatsukami Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 693 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Strasser, W. B. Pickworth, F. Patterson, and C. Lerman Smoking Topography Predicts Abstinence following Treatment with Nicotine Replacement Therapy Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1800 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-I. Proulx, A. Castonguay, and E. Y. Bissonnette Cytokine production by alveolar macrophages is down regulated by the {alpha}-methylhydroxylation pathway of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Carcinogenesis, June 1, 2004; 25(6): 997 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, K.-A. Le, S. E. Murphy, Y. S. Li, C. Le, J. Jensen, and D. K. Hatsukami Effects of Reduced Cigarette Smoking on Levels of 1-Hydroxypyrene in Urine Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A Rigotti and H. A Tindle The fallacy of "light" cigarettes BMJ, March 13, 2004; 328(7440): E278 - E279. [Full Text] [PDF]
|
|
|
|
|
|
N Gray and P Boyle The case of the disappearing nitrosamines: a potentially global phenomenon Tob. Control, March 1, 2004; 13(1): 13 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Leischow and M. V. Djordjevic Smoking Reduction and Tobacco-Related Cancers: The More Things Change, the More They Stay the Same J Natl Cancer Inst, January 21, 2004; 96(2): 86 - 87. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. E. Murphy, S. G. Carmella, C. L. Zimmerman, L. Losey, I. Kramarczuk, M. R. Roe, S. S. Puumala, Y. S. Li, C. Le, et al. Effects of Reduced Cigarette Smoking on the Uptake of a Tobacco-Specific Lung Carcinogen J Natl Cancer Inst, January 21, 2004; 96(2): 107 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A B Breland, M C Acosta, and T Eissenberg Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of AdvanceTM Tob. Control, September 1, 2003; 12(3): 317 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J E Muscat, J P Richie Jr, and S D Stellman Mentholated cigarettes and smoking habits in whites and blacks Tob. Control, December 1, 2002; 11(4): 368 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Shields Tobacco Smoking, Harm Reduction, and Biomarkers J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L S Lewis, L T Kozlowski, and R J O'Connor Filter vent blocking * Authors' reply Tob. Control, September 1, 2002; 11(3): 285 - 286. [Full Text]
|
|
|
|
|
|
S. S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis, June 1, 2002; 23(6): 907 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Slade, G N Connolly, and D Lymperis Eclipse: does it live up to its health claims? Tob. Control, June 1, 2002; 11(90002): ii64 - 70. [Abstract] [Full Text]
|
|
|
|
|
|
K Ueda, I Kawachi, M Nakamura, H Nogami, N Shirokawa, S Masui, A Okayama, and A Oshima Cigarette nicotine yields and nicotine intake among Japanese male workers Tob. Control, March 1, 2002; 11(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L T Kozlowski and R J O'Connor Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents Tob. Control, March 1, 2002; 11(90001): i40 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K M Cummings, C P Morley, and A Hyland Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking Tob. Control, March 1, 2002; 11(90001): i110 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T Kozlowski and J. L Pillitteri Beliefs about ""Light"" and ""Ultra Light"" cigarettes and efforts to change those beliefs: an overview of early efforts and published research Tob. Control, December 1, 2001; 10(90001): i12 - 16. [Full Text] [PDF]
|
|
|
|
|
|
S. Shiffman, J. L Pillitteri, S. L Burton, J. M Rohay, and J. G Gitchell Effect of health messages about ""Light"" and ""Ultra Light"" cigarettes on beliefs and quitting intent Tob. Control, December 1, 2001; 10(90001): i24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Canova, M. L Myers, D. E Smith, and J. Slade Changing the future of tobacco marketing by understanding the mistakes of the past: lessons from ""Lights"" Tob. Control, December 1, 2001; 10(90001): i43 - 44. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Stellman, T. Takezaki, L. Wang, Y. Chen, M. L. Citron, M. V. Djordjevic, S. Harlap, J. E. Muscat, A. I. Neugut, E. L. Wynder, et al. Smoking and Lung Cancer Risk in American and Japanese Men: An International Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1193 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Jarvis, R. Boreham, P. Primatesta, C. Feyerabend, and A. Bryant Nicotine Yield From Machine-Smoked Cigarettes and Nicotine Intakes in Smokers: Evidence From a Representative Population Survey J Natl Cancer Inst, January 17, 2001; 93(2): 134 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Peeler and G. R. Butters Re: It's Time for a Change: Cigarette Smokers Deserve Meaningful Information About Their Cigarettes J Natl Cancer Inst, May 17, 2000; 92(10): 842 - 842. [Full Text] [PDF]
|
|
|
|
|
|
J. Wilkenfeld, J. Henningfield, J. Slade, D. Burns, and J. Pinney It's Time for a Change: Cigarette Smokers Deserve Meaningful Information About Their Cigarettes J Natl Cancer Inst, January 19, 2000; 92(2): 90 - 92. [Full Text] [PDF]
|
|